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Abstract
The apoptotic programme is evolutionarily conserved betweenyeastand metazoan
organisms. We have previously identiﬁed a number of mammalian cDNAs capable
of suppressing the deleterious effects of Bax expression in yeast. We herein report
that one such suppressor, named Tsc22
(86), represents the C-terminal 86 amino
acids of the previously characterized leucine zipper (LZ) motif-containing
transcriptional regulator Tsc22. Employing a genome-wide two-hybrid screen,
functional genomics, and deletion mutagenesis approaches, we conclude that
Tsc22
(86)-mediated antiapoptosis is independent of the LZ motif and is likely
independent of effects on gene transcription. Rather, a 16-residue sequence within
the conserved 56-residue TSC22 domain is necessary for antiapoptosis. The
presence of a similar sequence was used to predict an antiapoptotic role for two
yeast proteins, Sno1p and Fyv10p. Overexpression and knock-out experiments
were used to validate this prediction. These ﬁndings demonstrate the potential of
studying heterologous proteins in yeast to uncover novel biological insights into
the regulation of apoptosis.
Introduction
Understanding the basic mechanisms of mammalian apop-
tosis has been facilitated by the genetic work done in the
metazoan worm Caenorhabditis elegans (Lettre & Hengart-
ner, 2006). Unicellular organisms, such as the yeast Sacchar-
omyces cerevisiae, have also been shown to undergo
apoptotic-like programmed cell death (CD). Although in-
itially controversial, the large and ever increasing body of
literature makes it quite clear that yeast undergoes a form of
PCD that is similar to the process of mitochondrial or
intrinsic apoptotic cell death that occurs in mammalian cells
(Madeo et al., 1999; Gourlay & Ayscough, 2005; Frohlich
et al., 2007). Yeast undergoing apoptotic-like cell death show
the typical hallmarks of a mammalian apoptotic cell such as
DNA cleavage, chromatin condensation and externalization
of phosphatidylserine, as well as an elevated level of reactive
oxygen species (ROS). These similarities are further evident
by the discovery that yeast apoptosis is also regulated by a
number of different proteins that have been shown to be
important in mammalian apoptosis. Yeast possess an AIF
(Apoptosis Inducing Factor; AIF), an AMID (AIF-homo-
logous Mitochondrion-associated Inducer of Death; NDI1),
a caspase (YCA1), an IAP (inhibitor of apoptosis; BIR1),
an Omi/Htr2A (NMA111), a DJ-1 (HSP31), as well as a
nuclease (TAT-D) that is a strong candidate to be involved
cell death mediated DNA degradation (Frohlich et al., 2007;
Skoneczna et al., 2007). Analyses of many of these proteins
show that they perform similar functions as their metazoan
counterparts. For example, it was recently reported that
the yeast ortholog of the Omi/Htr2A serine protease
(Nma111p) induces apoptosis in part by cleaving yeast IAP
Bir1p (Walter et al., 2006). Furthermore, overexpression of
the yeast pro-apoptotic proteins can serve to initiate or
enhance cell death while yeast strains lacking any of these
genes show a decrease response to a number of different
death stimuli (Madeo et al., 2002; Fahrenkrog et al., 2004).
In addition to the extensively studied antiapoptotic regula-
tors, such as antioxidant enzymes and heat shock proteins,
cells express a range of molecules that serve to prevent
apoptosis and other forms of cell death (Reed, 2004). Given
that the biochemical or molecular functions of many
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that much remains to be answered regarding the strategies
cells use to counter pro-apoptotic mechanism (Reed, 2004).
In addition, the response to oxidative stress is far more
pleiotropic than commonly described (Temple et al., 2005).
For example, as many as 600 different genes have been found
to be required for full resistance to oxidative stress while 900
or so genes have been shown to be induced by different
stresses (Winzeler et al., 1999; Gasch et al., 2000).
The process of antiapoptosis in yeast shows notable
similarities to mammalian cells. For example, MAP kinase
signalling cascades play important roles in counteracting the
effects of ER stress in yeast and mammalian cells (Hu et al.,
2004; Chen et al., 2005). Also, the analysis of the Parkinson’s
disease associated presynaptic protein a-synuclein has been
used as a tool to identify novel proteins that can prevent
endoplasmic reticulum (ER) stress-mediated cell death in
both yeast and metazoans (Zabrocki et al., 2005; Grifﬁoen
et al., 2006; Witt & Flower, 2006). The ability to screen
heterologous libraries to identify suppressors of the Bax-
mediated cell death in yeast has also served to shed light on
the process of antiapoptosis. For example, the identiﬁcation
of ROS scavenging proteins as suppressors of the lethal
effects of Bax expression clearly implicates the role of ROS
in PCD in yeast (Kampranis et al., 2000; Moon et al., 2002).
We have made a concerted effort to study the process of
antiapoptosis in yeast through the identiﬁcation of a num-
ber candidate antiapoptotic mammalian cDNAs effective in
preventing the inhibitory effects of Bax expression in yeast
(Yang et al., 2006; Khoury et al., 2007; Khoury & Green-
wood, 2008). The identiﬁcation of sphingomyelin synthase 1
(SMS1), a ceramide-depleting enzyme, as an antiapoptotic
sequence in yeast highlights the central role of sphingolipid
metabolism in yeast PCD (Yang et al., 2006).
In a previous report, human TSC22 was identiﬁed as one
of a number of suppressors of Bax-mediated cell death in
yeast (Yang et al., 2006). TSC22 was ﬁrst identiﬁed as a 144-
residue leucine zipper (LZ) motif-containing protein that
is up-regulated by transforming growth factor-b1 (TGF-b1
(Shibanuma et al., 1992). ‘TSC22’ is now a commonly
accepted denotation for a LZ motif-containing conserved
domain encoded for by a multi-gene family (Fiol et al.,
2007). Although the TSC22 domain is highly conserved
between the different TSC22 domain-containing proteins,
there appears to be distinct functional differences. For
example, some members are proapoptotic while others are
distinctly antiapoptotic (Kawamata et al., 2004; Fiol et al.,
2007). Although yeast does not have a Tsc22 ortholog, we
reasoned that its potential antiapoptotic effects in yeast
would likely function by its ability to interact with a LZ
transcription factor, reminiscent of the current model for
Tsc22 function in mammalian cells (Kester et al., 1999;
Kawamata et al., 2004). Here we report that the cDNA
encoding the C-terminal TSC22 domain of the human
TSC22-1 gene prevent yeast cell death in response to a
variety of apoptotic stimuli including the ROS donor
hydrogen peroxide (H2O2). Global two-hybrid analysis, the
analysis of yeast mutants lacking LZ transcription factors, as
well as the analysis of TSC22 deletions were used to
demonstrate that the LZ structure of TSC22 is not required
for this antiapoptotic function. Instead our analysis has lead
to the identiﬁcation of a 16 amino acid (aa) motif that is
required to confer protection against ROS inyeast.The 16aa
sequence is present in multiple proteins including four
different yeast proteins. The demonstration that two of
these proteins, Sno1p and Fyv10p, are indeed antiapoptotic
suggests that we have uncovered a new motif that confers
antiapoptotic effects.
Materials and methods
Yeast strains and plasmids
Strain BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0) was
used as the wild type strain. Strain KTY3 (pep4<kanMX,
prb1<LEU2,His3MX6-PGAL1-3HA<ERG6) contains a geno-
mic insertion of the GAL1 promoter upstream of the ERG6
coding sequence. Both this strain and its parental KTY1
(pep4<kanMX,act1-157<HIS3) were gifts from G. Eitzen.
All deletion mutants were isogenic to BY4741 and were
obtained from EUROSCARF (http://web.uni-frankfurt.de/
fb15/mikro/euroscarf/index.html). The Bax suppressors
(Sup. 12, Sup. 32, and Sup. 97) were previously isolated by
screening a human heart expression cDNA library in yeast
cells expressing Bax under the control of the GAL1 promoter
(Yang et al., 2006). The heart cDNA library and conse-
quently the Bax suppressors used in this study are cloned
into the galactose inducible pYES-DEST52 vector. The
sequences encoding TSC22-1v2, and TSC22-1v3, as well as
the TSC22
(86) deletion mutants were ampliﬁed by PCR
using either a heart cDNA library (Yang et al., 2006) or the
cDNA-encoding TSC22
(86) as a template. All the primers
used: in this study are described in Table 1. The TSC22
domains (and nonconserved C-terminal tails) encoded
by TSC22-2, TSC22-3, and TSC22-4 were also ampliﬁed by
PCR using either a human heart or skeletal muscle cDNA
library as template. All these PCR products were subcloned
into the yeast expression vector p426GAL1. For two hybrid
plasmids, the TSC22
(86) coding sequence was PCR ampliﬁed
and cloned by recombination in yeast into the vector
pOBD2 (McCraith et al., 2000) in frame with the Gal4
DNA-binding domain (Gal4DBD) (Yang et al., 2007). The
TSC22
(86) coding sequence was also PCR ampliﬁed and
cloned by recombination in yeast into the vector pLEXA-
dir (McCraith et al., 2000) in frame with the Lex DNA-
binding domain (LexADBD). The resulting constructs were
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Transcription Factor (TFs) (RTG1, RTG3 and CST6)w e r e
prepared for subcloning into the two-hybrid prey vector by
PCR ampliﬁcation from a yeast genomic library as a template.
The PCR products were subcloned in frame with Gal4 Activa-
tion Domain into plasmid pACT2 (Gyuris et al., 1993). The
ORFs encoding Sno1p and Fyv10p were ampliﬁed by PCR
using a yeast genomic library asat e m p l a t e .T h eP C Rp r o d u c t s
were subcloned in frame with green ﬂuorescent protein (GFP)
in vector p426GAL1-GFP (Somerville et al., 2003).
Yeast growth and transformations
Yeast cells were routinely grown in synthetic minimal media
containing Yeast nitrogen base (YNB), 2% glucose and the
required amino acids or base. Glucose was replaced with 2%
galactose and rafﬁnose for experiments in which induction
of the GAL1 promoter was required. ERG6 overexpression
experiments performed with the KTY1/KTY3 strains re-
quired the use of YNB, 1% each of galactose and glucose to
achievewild-type growth rates asdescribed in (Tedrick et al.,
2004). Transformations were performed using lithium acet-
ate and selection of transformants was achieved by omitting
speciﬁc amino acids or base for which auxotrophy was
conferred by the vectors.
Clonogenicity and cell survival assays
To assess the growth of yeast transformants expressing Bax
under the control of a galactose inducible promoter, freshly
Table 1. Sequences of the oligonucleotides used in this study
Name Oligonucleotides (50–30)
Expression
TSC22-1v2 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGGAGCCCCTACTGTGGTG
TSC22-1v3 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGAAATCCCAATGGTGTAGA
TSC22
(86) Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGATCTAGTGAAAAGCCAT
TSC22-1 Reverse GGTGGCGATGGATCCCGGGCCCGCGGTACCTGCGGTTGGTCCTGAGCCCTG
TSC22-2 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGATCTGGTGAAAAGCCAT
TSC22-2 Reverse GGTGGCGATGGATCCCGGGCCCGCGGTACCTTATGCTGAGGAGACATTCGG
TSC22-3 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGATCTGGTGAAGAATCAT
TSC22-3 Reverse GGTGGCGATGGATCCCGGGCCCGCGGTACCCACCGCAGAACCACCAGGGGC
TSC22-4 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGACTTGGTGAAGTCCCAC
TSC22-4 Reverse GGTGGCCATGGATCCCGGGCCCGCGGTACCTCAGACGGAGGGCCCATTGGG
TSC22
(D1 40) Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGAAGACACTGGCCAGTCCT
TSC22
(D1 40) Reverse GGTGGCGATGGATCCCGGGCCCGCGGTACCTGCGGTTGGTCCTGAGCCCTG
TSC22
(D1 56) Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGATATGCGGTCAGAGAAGAAGTC
TSC22
(D1 56) Reverse GGTGGCGATGGATCCCGGGCCCGCGGTACCTGCGGTTGGTCCTGAGCCCTG
TSC22
(D41 86) Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGATCTAGTGAAAAGCCAT
TSC22
(D41 86) Reverse GGT GGCCATGGATCCCGGGCCCGCGGTACCCAGCAGATTGTTGTTCTCCTG
TSC22
(D57 86) Forward TAGTGG ATCCCCCGGGCTGCAGGAATTCGAATGGATCTAGTGAAAAGCCAT
TSC22
(D57 86) Reverse GGTGGCCATGGATCCCGGGCCCGCGGTACCCTGGGCCTGAAACTGGGCAAG
SNO1 Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGCACAAAACCCACAGTACA
SNO1 Reverse GGTGGCCATGGATCCCGGGCCCGCGGTACCATTAGAAACAAACTGTCTGAT
FYV10Forward TAGTGGATCCCCCGGGCTGCAGGAATTCGAATGGCAGAGAAATCAATATTT
FYV10 Reverse GGTGGCCATGGATCCCGGGCCCGCGGTACCGGTTGGGTACATTTTGATAGA
TSC22
(86)2byb Forward CCAAAAAAAGAGATCGAATTCCAGCTGACCATGGATCTAGTGAAAAGCCAT
TSC22
(86)2byb Reverse ATCTCTGCAGGTCGACGGATCCCCGGGAATCTATGCGGTTGGTCCTGAGCC
RTG1 Forward AGCTTGGGTGGTCATATGGCCATGGAGGCCATGAGCAGCATTCCAGCTGGC
RTG1 Reverse GTTTTTCAGTATCTACGATTCATAGATCTCTTAGCTACCATTACCGTACTC
RTG3 Forward AGCTTGGGTGGTCATATGGCCATGGAGGCCATGATGAACAATAACGAAAGT
RTG3 Reverse GTTTTTCAGTATCTACGATTCATAGATCTCCTACCCCGAACCAAATTCTAA
CST6 Forward AGCTTGGGTGGTCATATGGCCATGGAGGCCATGTTTACTGGTCAGGAGTAT
CST6 Reverse GTTTTTCAGTATCTACGATTCATAGATCTCTTTATCTTTTCAGAATT
RT-PCR
TSC22-1v1 Forward AGGGAGAGCACTAGTGGGAGT
TSC22-1v1 Reverse ATCTGTGACTGAGAAATACTC
TSC22-1v2 Forward TTGGTTCAAAGTGTTAGTCAA
TSC22-1v2 Reverse ATAGCTACCACACTTGCACCA
TSC22-1v3 Forward TGGCTGCAATTGCATGAAATC
TSC22-1v3 Reverse GCAATGAAATGGGTGACTGTG
b-actin Forward GTGGGCCGCCCTAGGCACCAG
b-actin Reverse CTCTTTGATGTCACGCACGATTTC
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media were diluted 10-fold in water and normalized for cell
number. 7.5-fold serial dilutions of these suspensions were
spotted on galactose (inducing) and glucose (noninducing)
media and thereafter incubated for 3–5 daysat 30 or 371Ca s
indicated. Results shown are representative of at least three
independent experiments. For treatments with H2O2,
saturated overnight cultures were diluted in fresh, galac-
tose-containing media, incubated for 4h to induce gene
expression, and subsequently treated with the indicated
concentration of H2O2. In some experiments, cells treated
in this manner were plated directly onto minimal media
and either irradiated with 100Jm
 2 with UV light or
incubated at 381C. Aliquots of different 7.5-fold serial
dilutions were then spotted on selective, glucose-containing
minimal media. For experiments involving yeast cells lack-
ing NKP1, the outgrowth period in galactose-containing
media was 6h. Viability was determined using the vital dye
trypan blue (Yang et al., 2006). Samples were removed at the
indicated time points, incubated for 5minwith 0.1% trypan
blue and subsequently examined microscopically. Similar
results were observed in at least three different experiments
for all the growth assays shown.
Reverse transcriptase (RT)-PCR
RNA was extracted from cultured cells and tissue samples
using RNAzol as previously described (Jean-Baptiste et al.,
2005; Yang et al., 2005). One mg of total RNA was reverse
transcribed and ampliﬁed by PCR using the ThermoScript
RT-PCR system (Invitrogen). Equal aliquots of cDNA were
used to amplify the various TSC22-1 transcripts using the
following conditions: 941C for 30s, 571C for 30s, 721C for
40s for a total of 35 cycles. The primers used are described
in Table 1. b-Actin mRNA was ampliﬁed as previously
described (Jean-Baptiste et al., 2005; Yang et al., 2005). An
aliquot of each PCR reaction was separated by electrophor-
esis on a 1.5% agarose gel stained with ethidium bromide,
visualized and photographed under UV illumination.
ROS detection
To detect accumulated intracellular ROS, aliquots of over-
night cultures of yeast grown in selective glucose mediawere
washed with sterile water, resuspended in galactose-contain-
ing media at an OD600nm of c. 0.1, and incubated at 301C.
After 12h, dihydrorhodamine 123 (DHR 123) was added to
ﬁnal concentration of 0.1mgmL
 1 and the cultures were
further incubated for an additional 2h. Cells were washed
twice with water and visualized using ﬂuorescent micro-
scopy through a rhodamine optical ﬁlter (Zeiss Axiovert).
The images were photographed and analyzed using NORTH-
ERN ECLIPSE software.
Induction of YCA1-induced apoptosis
Plasmid pFM21 (a gift from F. Madeo) which contains a HA
tagged YCA1 gene expressed under control of the GAL1
promoter was used to express YCA1. To assess the effects of
TSC22
(86) expression on YCA1 mediated apoptosis was
assessed in BY4741 cells harbouring pFM21 as described
(Madeo et al., 2002). Brieﬂy, exponentially growing cells in
galactose minimal media were treated with 0.4mM H2O2
for 16h in order to activate yca1p. Under these conditions,
the viability of control cells expressing TSC22
(86) alone was
94 4% while cells harbouring the YCA1 expressing plas-
mid was decreased 58.66 ( 4.48) %. Viability was deter-
mined using the vital dye trypan blue as described above.
Genome-wide yeast two-hybrid screen
The pODB-TSC22
(86) construct was transformed into yeast
strain pJ69-4a. Two individual clones resulting from this
transformation were mated against the activation domain
(Gal4p-AD) array in PJ69-4a, as described (Uetz et al., 2000;
Hazbun et al., 2003). Diploids that grew in media lacking
histidine, indicating expression of the HIS3 gene under the
promoter of the GAL1 gene, were scored as putative inter-
action partners. Yeast strains expressing the Gal4p-AD–yeast
ORF fusions corresponding to the eight positives identiﬁed
in the genome-wide assay were selected from the array, and
rescreened in a small-scale format against strains expressing
Gal4p-DBD-TSC22. Strains expressing the Gal4p DNA-
binding domain and activation domain, as well as a well-
established interacting pair (Rad17p/Mec3p), were included
as speciﬁcity controls.
Yeast two-hybrid assay
Different combinations of the two-hybrid plasmids were
transformed into the yeast strain DSY-1 (MATa his3D200
trp1-901 leu2-3,112 ade2 LYS2<(lexAop)4-HIS3 URA3<
(lexAop)8-lacZ GAL4). Freshly saturated cultured of the
transformed were serially diluted and spotted onto YNB
glucose agar plates with and without histidine (Yang et al.,
2007).
Results
Bax suppressor 51 (Sup.51) represents the
C-terminal region of Tsc22 and prevents the
effects of apoptotic stimuli in yeast
An 86aa ORFcorresponding to the C-terminus of the 144aa
human Tsc22 protein was previously identiﬁed as a suppres-
sor of the lethal effects of expressing a proapoptotic Bax
cDNA in yeast (Yang et al., 2006). The N-terminal 56
residues of this clone represents the conserved TSC22
domain (Fig. 1b) (Kester et al., 1999). Although Bax
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543 Functional analysis of human Tsc22 in yeastexpression in yeast leads to apoptosis, it remains possible
that the expression of a cDNA may suppress the effects of
Bax by simply promoting cell growth. As a ﬁrst step towards
characterizing our TSC22 clone, henceforth called
TSC22
(86), we determined if it could prevent the effects of
other apoptosis-inducing stimuli when expressed in yeast.
Elevations in the levels of intracellular ROS trigger apoptotic
cell death in both yeast and mammalian cells (Zamzami
et al., 1995; Madeo et al., 1999). A low dose of H2O2 has
been shown to promote apoptotic cell death by increasing
intracellular ROS and is commonly used to induce yeast
apoptosis. Yeast cells expressing the TSC22
(86) clone dis-
played a markedly enhanced ability to form colonies on
solid growth media after treatment with 4mM H2O2, when
compared to cells harboring empty vectors (Fig. 1c). This
effect was observed at both 2 and 3h posttreatment. These
data indicate that Tsc22
(86) likely functions as an antiapop-
totic protein in yeast (see also below).
The human TSC22 gene encodes for multiple
transcripts that specify different proteins with
prosurvival functions in yeast
In addition to the previously characterized 144-residue
Tsc22 protein, the database searches of human proteins
using Tsc22
(86) revealed identical matches with the
C-terminal 86aa of two other Tsc22 proteins of 585 and
742aa. The three differently sized Tsc22 proteins share an
identical 86 residue C-terminal region but differ in their
N-terminal portions (Fig. 2a). The common C-terminus is
comprised partly by 56 residues that are deﬁned as a TSC22
domain (Kester et al., 1999). The remaining portion that is
identical between the three Tsc22 proteins is comprised of
the 30 residues that serve as the C-terminal tail. These
observations suggested that the TSC22 gene is likely alter-
natively spliced to produce multiple transcripts. In spite of
this diversity, the 144-residue isoform is the one that is
commonly referred to as Tsc22 (Kawamata et al., 2004).
In order to investigate the origin of the different TSC22
transcripts and proteins, we set out to characterize the
organization of the human TSC22 gene. To accomplish this,
we used BLAST to compare the sequences of the different
TSC22 cDNAs to the sequence of the human genome. The
TSC22 gene was found to consist of four different exons that
are spread over at least 141.6kb of DNA found on chromo-
some 13 (Fig. 2a). The common 56aa containing the TSC22
domain and C-terminal 30 residues, as well as the transla-
tional stop site are all encoded by exon 4 exclusively
(Fig. 2a). The 18-aa sequence at the N-terminus of the
TSC22 domain that is common to all three proteins is
encoded by exon 3. All three TSC22 transcripts contain
exons 3 and 4. The observed differences between the three
TSC22 transcripts are due to alternative splicing of exons
1 and 2 (Fig. 2a). The alternatively spliced variant 3
Fig. 1. Sup. 51 represents the C-terminal
region of Tsc22 and protects yeast cells from the
effects of H2O2. (a) The amino acid sequence of
Sup. 51 is shown aligned to the 144-residue
human Tsc22 (GenBank accession #
NT_024524). (b) A schematic representation of
the domain organization of Tsc22
(86). ‘The con-
served TSC-22 domain’shown in red. The loca-
tions of the leucine (L) and valine (V) residues
that form the LZ are shown. The domain spans
residues Met
1(M1)-Leu
56(L56), and is succeeded
by a variable C-terminal region spanning resi-
dues Gln
57(Q57)-Ala
86(A86). The predicted ‘LZ’
motif embedded within the TSC22 domain is
present between residues V12-L40. (c) Wild
Type yeast cells transformed with the indicated
constructs were grown to logarithmic phase in
galactose-containing minimal media. Aliquots
of each culturewerenormalized forcell number,
serially diluted, and then spotted on nutrient-
containing agar media (CONTROL). Four (4)
millimolar H2O2 was added to each culture and
aliquots were removed after 2 and 3h, serially
diluted, and spotted on nutrient-containing
media. All plates were incubated for 3 days
at 301C.
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544 C.M. Khoury et al.(TSC22v3) contains exon 2 at its 50 end (Fig. 2a). This exon
contains the predicted translational start site and the unique
N-terminus that is present only in the 144aa Tsc22v3
protein (Fig. 2a). The TSC22v1 mRNA consists of exons 1,
3 and 4 (Fig. 2a). Exon 1 provides its 50 end, the predicted
translational start site and the unique N-terminus that is
present only in the 742-residue Tsc22v1 protein (Fig. 2a). In
contrast, the TSC22v2-encoded 585-residue protein is an N-
terminally truncated form of the 742-residue TSC22v3
protein (Fig. 2a). The 50 end of the TSC22v2 transcript
consists of exons 1A and 1B (Fig. 2a). These are cryptic
exons that are part of the larger exon 1 used to make the 50
end of the TSC22v1 transcript. The translational start site
used to make the 585-residue TSC22v2 protein is predicted
to be at the 50 end of exon 1B (Fig. 2a).
The sizes of the different exons and the sequences of the
intron/exon boundaries of the TSC22 gene were determined
by comparing the sequences of the genomic DNA and the
sequences of the different cDNAs (Table 2). All the exon/
intron boundaries follow the GT/AG rule for splice sites.
To conﬁrm that the cDNAs are not artifacts of the cDNA
library from which they were cloned and actually represent
endogenously expressed transcripts, we performed an RT-
PCR analysis of the TSC22 gene products using primers that
recognized both the human- and mouse-encoded tran-
scripts (Fig. 2b). Three sets of primers were used in order
to speciﬁcally detect the transcripts. We observed expression
of TSC22v3 in a number of mouse tissues with prominent
levels of the transcript detected in the heart, lung, spleen,
and the cardiac HL-1 cell line (Fig. 2b). The TSC22 v1
transcript was also detected in a range of mouse tissues. Due
to the lackof unique regions in the v2 transcript with respect
to v1, we were unable to ascertain the expression pattern for
v2 alone. Nevertheless, we found that v2 is expressed in
brain, spleen, kidney, and testis since v1 was not detected
in these tissues. We also examined the expression of TSC22-
encoded transcripts in human cells. We found readily
detectable levels of the v1 and v3 transcripts in HEK293
cells, but were unable to detect expression in cDNA libraries
prepared from either human fetal brain or skeletal muscle
extracts (Fig. 2b). b-Actinwas detected in all tissues and cells
examined and served as a loading control for these studies.
This analysis indicates that three TSC22 gene products are
Fig. 2. Analysis and characterization of the alternatively spliced TSC22
transcripts. (a) A schematic representation of the genomic organization
of human TSC22. The sequences of all human TSC22 cDNAs available in
GenBank were compared to the sequence of the human genome using
BLAST in order to determine the exon composition of the TSC22 gene. The
four exons of TSC22 are shown at the top of the Figure as boxes
numbered ‘1’–‘4’. The locations of the cryptic exons ‘1a’ and ‘1b’ that
are present within exon 1 are indicated. The exon composition of the
different TSC22 transcripts is shown boxed. The locations of the transla-
tional start (ATG) and stop (STOP) codons are also indicated. The coding
sequences are shown in color while the 50 and 30 UTRs are shown as
empty boxes. Arrows are used to depict the location of the oligos used
for RT-PCR. At the bottom are representations of the three predicted
Tsc22 proteins produced by the alternatively spliced transcripts. Different
regions of the proteins are color-coded and correspond to the similarly
colored mRNA sequence from which they are encoded. The region of the
conserved TSC22 box is shown in red. The names of the different
proteins are shown at the left (‘v’= splice variant), while their sizes are
indicated at the right. The 86aa protein encoded by the TSC22
(86) cDNA
is also shown. The location of the start codon (ATG) for this cDNA is
shown as ‘ATG’. (b) RT-PCR analysis of the expression of the three
TSC22 transcripts. Total RNA was isolated from a variety of mouse tissues
and cell lines (MOUSE), as well as human cells (HUMAN). RT-PCR was
used to amplify the TSC22 transcripts using specific oligos. The different
mouse tissues are: 1, brain; 2, heart; 3, lung; 4, liver; 5, spleen; 6, kidney;
7, testis; 8, skeletal muscle; 9, HL-1; 10, C2C121vehicle; 11,
C2C121TNF-a (50ngmL
 1). The human cell lines are: 12, HEK293; 13,
fetal brain; 14, skeletal muscle cDNA libraries. b-Actin was also amplified
using specific oligos and served as an internal control. (c) Wild Type yeast
cells transformed with vectors expressing the indicated Tsc22 proteins
were grownto logarithmic phase in galactose-containing minimal media.
Aliquots of each culture were normalized for cell number, serially diluted,
and then spotted on nutrient-containing agar media before (CTL) and 2
or 3h after treatment with 4mM H2O2. The plates were incubated for 3
days at 301C.
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545 Functional analysis of human Tsc22 in yeastexpressed endogenously in a variety of mouse tissues and at
least two of these transcripts are expressed in a human cell line.
The TSC22 cDNA that we isolated in our Bax suppressor
screen, TSC22
(86), encodes for the 86 C-terminal residues of
Tsc22 that is present in all three Tsc22 proteins produced by
the alternately spliced TSC22 gene (Fig. 2a). Itconsists of the
entire 4th exon and also contains the 30 end of exon 3 that
supplies its predicted translational start site (Fig. 2a). Given
that there is no unique sequence present in the TSC22
(86)
cDNA, we were unable to use RT-PCR to determine if it
represents a fourth TSC22 splice variant or if the cDNA
represents a truncated version of one of the 3 known TSC22
transcripts. We therefore wondered if the antiapoptotic
effect observed with the expression of TSC22
(86) is a
potential artifact due to the expression of a truncated form
of TSC22. We thus sought to determine whether the
endogenously expressed TSC-22 gene products could also
function to promote cell survival in yeast. Cells transformed
with vectors expressing a cDNA encoding the 144-residue
Tsc22v3 displayed an enhanced ability to grow, as compared
to empty vector-transformed cells, after treatment with
H2O2 (Fig. 2c). This effect, noted after both a 2- and a 3-h
treatment, was also observed with cells transformed with a
vector expressing a cDNA encoding the 585-residue Tsc22v2
(Fig. 2c). The prosurvival effect was consistently less marked
than that conferred by TSC22
(86). While we have not
compared expression levels, this could explain the differ-
ences in the protective effect of the different Tsc22 isoforms.
Nevertheless, these observations demonstrate that Tsc22
proteins have a pro-survival effect in yeast.
The conserved TSC22 domain defines a
four-member gene family
Analysis of the TSC22 sequence in GenBank also revealed a
large number of human cDNAs that contained regions with
high sequence identity to TSC22
(86). The highest sequence
identity was present in the regions coding for the TSC22
domain. This suggested that the conserved TSC22 domain
is part of a multi-gene family. Although most published
studies pertaining to Tsc22 refer to the 144-residue product
of the TSC22v3 transcript we described in the previous
section (Fig. 2a), a level of ambiguity exists in the current
literature as to which TSC22 containing gene and which
alternatively spliced variant is actually being studied. In
order to clearly describe the human gene family and classify
the various gene products, we used BLAST to compare the
sequences of all the available human cDNAs to the sequence
of the human genome. The results of this analysis revealed
that there are four different human genes containing TSC22
domain-encoding regions (Figs 2 and 3). For clarity and to
conform to the information available in some of the
published reports, we named the genes TSC22-1 to TSC22-4
(Fiol et al., 2007). TSC22-1 corresponds to the founding
member of the gene family and to the TSC22 gene described
in Fig. 2(Jay et al., 1996). Human TSC22-2 consists of five
exons that are spread over at least 51.1kb of DNA located on
chromosome 3 (Fig. 3a). Three different transcripts (v1 to
v3) that are produced by alternative splicing were identified
from the TSC22-2 gene. Three different proteins all contain-
ing the TSC22 domain, ranging in size from 84 to 710aa are
also predicted to be produced (Fig. 3a). Human TSC22-3,
which encodes the well-studied GILZ protein (Asselin-
Labatt et al., 2004), also consists of five exons that are spread
over at least 62.6kb of DNA that is located on chromosome
X (Fig. 3b). Three different transcripts (v1–v3) that are
produced by alternative splicing were identified from
the TSC22-3 gene. Three different proteins all containing
the TSC22 domain, ranging in size from 77 to 200aa arealso
predicted to be produced (Fig. 3b). Human TSC22-4 also
consists of five exons that are spread over at least 12.7kb of
DNA that is located on chromosome 7 (Fig. 3c). Similar to
the other TSC22 genes, TSC22-4 is also predicted to generate
three different transcripts (v1–v3) that are produced by
Table 2. Sequences of the exon–intron junctions of the alternatively spliced human TSC22-1 gene
Exon Exon size (bp) Splice acceptor site (intron–EXON) Splice donor site (EXON–intron)
1 41957 50end GAGAG-gtaag
1a 4140 50end ATAAA-gtggt
1b 1456 ggaag-TGGAG GAGAG-gtaag
2 307 50end AATAG-gtaaa
3 52 ttcag-CTCCT CTATG-gtatg
4 1362 tccag-GATCT TTGAT=polyA
The intron/exon boundaries were determined by comparing the sequences of the longest human cDNAs corresponding to the three different TSC22-1
transcripts (GenBank accession numbers: AK027071 for TSC22-1v1; CR627459 for TSC22-1v2; U35048 for TSC22-1-v3) with the corresponding
genomic DNA sequence found on chromosome 3 (GenBank accession number NT_024524). Introns are shown in lower case and exons in upper case
letters.
Exons 1, 1a, 2 are used for the 50 ends of TSC22-1v1, v2, and v3 transcripts, respectively. Exons 1a and 1b contain alternately spliced regions of exon1
and are both used to encode the TSC22-1v1 transcript.
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546 C.M. Khoury et al.Fig. 3. TSC22 is a memberof a multi-gene family with other antiapoptotic members. Schematic representations of the organization of human TSC22-2
(a), TSC22-3 (b), and TSC22-4 (c) genes. The sequences of all human TSC22-related cDNAs available in GenBank were compared to the sequence of
the human genome using BLAST in order to determine the exon composition of the TSC22 genes. The five exons of each gene are shown at the top of the
Figure as boxes numbered ‘1’–‘5’. The locations of the cryptic exons ‘1a’ and ‘1b’ that are located within exon 1 of TSC22-2 and TSC22-3 are indicated.
Similarly, Cryptic exon ‘5a’ is indicated in exon 5 of TSC22-2, as well as cryptic exons ‘2a’ and ‘3a’ in exons 2 and 3, respectively of TSC22-4. The exon
composition of the different TSC22 transcripts is shown boxed. The locations of the translational start (ATG) and stop (STOP) codons are also indicated.
The coding sequences are shown in color while the 50 and 30 UTRs are shown as empty boxes. At the bottom are representations of the three predicted
Tsc22 proteins produced by the alternatively spliced transcripts. Different regions of the proteins are color-coded and correspond to the similarly colored
cDNA sequence from which they areencoded. The regionof the conserved TSC22 box is shown in red. The names of the different proteins areshown at
the left (‘v’= splice variant), while their sizes are indicated at the right. (d) An alignment of the TSC22 domains of the four Tsc22 family members.
Residues identical to Tsc22-1 are shown in red. An asterisk () is used to indicate residues that are identical between all four sequences. (e) The
amino acid sequences of the different TSC22 sequences from all four human genes were compared in a pair-wise manner. The percentage of sequence
identity between the different family members was determined and is shown boxed. (f) Wild-type yeast cells transformed with the indicated
vectors were grown to logarithmic phase in galactose-containing minimal media. Aliquots of each culture were normalized for cell number, serially
diluted, and then spotted on nutrient-containing agar media before (CTL) and 2 or 3h after treatment with 4mM H2O2. The plates were incubated for
3 days at 301C.
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from 195 to 395aa are also predicted to be produced (Fig.
3c). In contrast to the other three TSC22 genes, only two of
the TSC22-4 proteins, Tsc22-4v1 and Tsc22-4v3, contain the
TSC22 domain. TSC22-4v2 is made up of exons 1–3 and
lacks exons 4 and 5 that encode for the TSC22 domain. It
should be noted that the TSC22-2 and TSC22-3 genes
produce a respective 87 and 77 residue protein that contains
the TSC22 domain at their N-terminus, similar to the 86aa
protein encoded by our TSC22
(86) clone. This indicates that
the TSC22-1 gene encoding an 86-residue splice variant
would not be unique in this regard and suggests that the
TSC22
(86) may represent a bona fide TSC22-1 transcript.
The sizes of the different exons and the sequences of the
intron/exon boundaries were determined for TSC22-2, -3
and -4 bycomparing the sequencesof the genomic DNAand
the sequences of the different cDNAs (Tables 3–5). All the
exon/intron boundaries follow the GT/AG rule for splice
sites.
The Tsc22-1v1 and Tsc22-2v1 proteins have similar
sizes (742 and 780aa, respectively) and they display a 30%
identity throughout this sequence, suggesting a common
ancestry (not shown). Apart from this, the sequence simi-
larity between the four Tsc22 proteins is largely limited to
the TSC22 domain. The amino acid sequences of the TSC22
domain of all four proteins are shown aligned in Fig. 3d.
All four proteins display a number of conserved residues
including the presence of the previously described putative
LZ motif (Jay et al., 1996). Pair-wise comparisons revealed
that the TSC22 domain of Tsc22-1 is most similar to that of
Table 4. Sequences of the exon–intron junctions of the alternatively
spliced human TSC-22-3 gene
Exon Exon size (bp)
Splice acceptor site
(intron–EXON)
Splice donor site
(EXON–intron)
1 4688 50end CACAG-gtggg
1a 4162 50end CACAG-gtccg
1b 412 tccag-GCACC CACAG-gtggg
2 4372 50end AACAG-gtaac
3 4167 50end CGCCG-gtagg
4 52 ggcag-TGCCT CCATG-gtgag
5 1529 ggcag-GATCT TTTCT=30end-polyA
The intron/exon boundaries were determined by comparing the
sequences of the longest human cDNAs corresponding to the four
different TSC-22 #3 transcripts (GenBank accession numbers:
NM_198057 and AK092645 for TSC-22-3-V1; NM_004089 for TSC-22-
3-V2; NM_00101588 for TSC-22-3-V3) with the corresponding genomic
DNA sequence found on chromosome X (GenBank accession number
NT_011651). Introns are shown in lower case and exons in upper case
letters.
Exons 1, 2, and 3, are used for the 50 ends of TSC-22-3-V1, V2, and V3
transcripts, respectively. Exons 1a and 1b contain respective 50 and 30
portions of exon1 and are used for two different transcripts specifying
a unique protein, TSC-22-3-V1.
Table 3. Sequences of the exon–intron junctions of the alternatively
spliced human TSC-22-2 gene
Exon Exon size (bp)
Splice acceptor site
(intron–EXON)
Splice donor site
(EXON–intron)
1 42308 50end GACAG-gtatg
1a 4130 50end GACAG-gtatg
1b 4101 50end GACAG-gtatg
2 72 cacag-GAATC GATAG-gtatg
3 157 gctag-AATTT AATTG-gtaag
4 52 tccag-TGCAT CAATG-gtaag
5 1469 cacag-GATCT 30end
5a 41742 cacag-GATCT TTTCT=30end-polyA
The intron/exon boundaries were determined by comparing the
sequences of the longest human cDNAs corresponding to the three
different TSC-22-2 transcripts (GenBank accession numbers:
NM_014779 for TSC-22-2-V1; AF201291 for TSC-22-2-V2; AF201292
for TSC-22-2-V3) with the corresponding genomic DNA sequence found
on chromosome 2 (GenBank accession number NT_005612). Introns are
shown in lower case and exons in upper case letters.
Exons 1, 1a, and 1b are used for the 50 ends of TSC-22-3-V1, V2, and
V3transcripts, respectively.Exons 1aand 1b containalternate 30 portions
of exon1 and are used for two different transcripts encoding TSC-22-2-
V3 and TSC-22-2-V2, respectively. Exon 5a contains an alternately
spliced region of both TSC-22-2-V1 and TSC-22-2-V3 transcripts.
Table 5. Sequences of the exon–intron junctions of the alternatively
spliced human TSC22-4 gene
Exon
Exon
size (bp)
Splice acceptor site
(intron–EXON)
Donor acceptor site
(EXON–intron)
1 4486 50end GGCCCCAGAG-gtagggttca
2 1031 ctttttccag-
TTTGCAAACT
ATGGGGGCAG-gtaagacctg
2a 183 accccagcag-
CGCCCCCCAG
ATGGGGGCAG-gtaagacctg
3 543 ccgcctccag-
GTGCCCCCAC
GAAACTTGAA=
30end-polyA
3a ccgcctccag-
GTGCCCCCAC
ACGATGATAG-
gtaggtgggc
4 49 gtctctccag-
TGGCTCCGGA
GCAAGCCATG-
gtaagagaag
5 650 gggcccccag-
GACTTGGTGA
GAAACTTGAA=
30end-polyA
The intron/exon boundaries were determined by comparing the
sequences of the longest human cDNAs corresponding to the three
different TSC22-4 transcripts (GenBank accession numbers: BC001486
for TSC22-4v1; BC031622 for TSC22-4v2; CR606606 for TSC22-4v3)
with the corresponding genomic DNA sequence found on chromosome
7 (GenBank accession number CH236956). Introns are shown in lower
case and exons in upper case letters.
Exon 1 is present at the 50 end of all four TSC-22 #4 transcripts. Exon 2a
contains a 30 portion of exon2 and is used for the TSC22-4v2 transcript.
Exon 3a contains the 50 portion of exon 3 and is used for the TSC22-4v1
and v3 transcripts.
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548 C.M. Khoury et al.Tsc22-4 (84% sequence identity) while the TSC22 domains
of Tsc22-2 and Tsc22-3 display slightly lower sequence
identity at 75% each (Fig. 3e). Although the TSC22 domain
is highly conserved across a number of metazoan species, its
precise function is at present uncertain. With the exception
of the predicted LZmotif, there are no other proteins with
similar sequences in the GenBank database. Similarly, we
found no clues as to the function of the non-TSC22 portion
of Tsc22
(86) in GenBank. We did discover a 46aa region
within the N-terminal non-TSC22 regions of the longest
Tsc22 proteins, Tsc22-1v1 and Tsc22-2v1, that display con-
siderable sequence identity (50% identity between residues
59–103 of Tsc22-1v1 aligned to residues 145–190 of Tsc22-
2v1) (Figs 2 and 3). These sequences are not present in other
proteins in GenBank and their functional signiﬁcance is at
present unknown.
The 144-residue product of the TSC22-1 gene has been
shown to be either pro- or antiapoptotic depending on the
cell type examined (Kawamata et al., 2004). Although not
all TSC22 domain-containing proteins have been tested,
it is probable, based on sequence similarity, that other
members of this family are also involved in mediating or
preventing apoptosis (Asselin-Labatt et al., 2004). Because
the products of the TSC22-1 gene can protect from the
effects of apoptotic stimuli in yeast (Fig. 2), we examined
the potential pro-survival functions of all Tsc22 proteins in
yeast by expressing cDNAs corresponding to the TSC22
domains (including the variable C-terminal tail) from the
four TSC22 genes. Yeast transformants expressing the
individual TSC22 domains were challenged with H2O2,
diluted and spotted onto nutrient agar plates to determine
their ability to grow. In addition to that from TSC22-1, the
TSC22 domain of TSC22-4 was also found to confer
resistance to H2O2 (Fig. 3f). This indicates that the anti-
apoptotic property of TSC22 is not limited to the motif
encoded by TSC22-1, but extends to that encoded by
TSC22-4 as well.
TSC22
(86) is antiapoptotic in yeast
An antiapoptotic protein should, by deﬁnition, prevent cell
death in response to apoptotic stimuli (Kroemer et al.,
2005). To examine if TSC22
(86) is antiapoptotic in yeast, we
directly assayed for the viability of TSC22
(86)-expressing
cells following apoptotic stimuli. Microscopic examination
of cells stained with the vital dye trypan blue revealed that
47.8 ( 3.0) % of cells excluded the dye after 16h of
induction of the expression of mouse BAX (Fig. 4a). In
contrast, 73.2 ( 1.4) % of cells coexpressing TSC22
(86)
retained viability, indicating the ability of TSC22
(86) to
protect from the lethal effects of BAX expression (Fig. 4a).
Similarly, 59.7 ( 3.0) % of empty vector-transformed
cells remained viable after a 5h treatment with 5mM
H2O2, while the proportion of viable cells was signiﬁcantly
higher at 82.0 ( 2.6) % in yeast expressing TSC-22
(86)
(Fig. 4b).
Yeast cells produce a caspase-like protein encoded by the
YCA1 gene that serves to induce apoptosis (Madeo et al.,
2002). Evidence for the importance of YCA1 comes from
studies showing that its overexpression induces apoptosis,
while yeastcells lacking this gene display increased resistance
to apoptosis-inducing stresses. We therefore tested the effect
of TSC22
(86) on the cell death induced by YCA1 overexpres-
sion (Fig. 4c). The viability of yeast cells harbouring
different combinations of plasmids was determined using a
vital dye. The viability of cells overexpressing YCA1 is
decreased to 58.7 ( 4.5) % when compared to control cells
harbouring an empty vector. The coexpression of TSC22
(86)
with YCA1 resulted in an increased viability of cells to 92.9
( 7.3) % (Fig. 4c).
Finally, it is well established that many apoptotic stimuli,
including H2O2, induce cell death in both mammalian and
yeast cells by increasing the intracellular levels of ROS
(Zamzami et al., 1995; Madeo et al., 1999). An increased
production of endogenous ROS is known to occur during
the apoptotic programme in yeast and is a commonly used
marker for apoptosis (Frohlich et al., 2007). We tested the
effect of TSC22
(86) on the H2O2-induced accumulation of
ROS detected with the cell-permeable probe DHR123, a
molecule that is converted into the ﬂuorescent compound
rhodamine upon oxidation (Fig. 4d). Empty vector-trans-
formed cells displayed an undetectable level of ﬂuorescence,
indicating the relatively low basal level of endogenous ROS
present in these cells. After a 4-h treatment with H2O2 the
proportion of ﬂuorescent cells observed was 65.3 ( 2.6) %.
The percentage of ﬂuorescent TSC22
(86)-expressing cells was
reduced to 11.6 ( 3.5) %, suggesting that TSC22
(86) ex-
pression prevents the accumulation of endogenous ROS in
yeast cells challenged with an apoptotic stimulus. Taken
together, these data indicate an antiapoptotic function for
TSC22
(86) in yeast.
A genome-wide two-hybrid screen for TSC22
(86)-
interacting yeast proteins
The yeast genome encodes 184 putative LZ-containing
proteins, 19 of which are TFs [Comprehensive Yeast
Genome Database, MIPS, (http://mips.gsf.de) (Mewes
et al., 2006)]. None of these proteins appear to be orthologs
of Tsc22
(86). Despite this, we hypothesized that the pro-
survival effect of expressing TSC22
(86) inyeast is the result of
the protein competing with an endogenous LZ-containing
TF protein for the formation of a dimeric complex. This
hypothesis is based on the observation that Tsc22 appears to
act as a transcriptional modulator in mammalian cells
despite the absence of a transcriptionally active domain
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LZ-containing TF has also been proposed to be responsible
for at least some of the functions of different Tsc22 proteins
when overexpressed in mammalian cells (Kester et al., 1999;
Hino et al., 2002). Nevertheless, only the Tsc22-4v3 protein
has been identiﬁed as a Tsc22-1v3 binding partner, and this
protein does not have an apparent yeast ortholog (Kester
et al., 1999). The yeast two-hybrid assay has been previously
used to screen for interactions between LZ-containing
proteins (Strathmann et al., 2001; Weltmeier et al., 2006).
To try and identify potential Tsc22
(86)-interacting proteins,
we performed a genome-wide two-hybrid screen. Yeast
strains carrying the Tsc22
(86) protein as a Gal4p DNA-
binding domain hybrid were tested in duplicate against an
array of c. 6000 yeast colonies. Each colony is derived from a
transformation with a plasmid containing a DNA fragment
Fig. 4. Overexpression of human TSC22
(86) is antiapoptotic in yeast. (a) Wild-type cells harbouring an empty plasmids (VECTORS), a plasmid expressing
Bax alone (BAX) or in combination with a plasmid expressing TSC22
(86) were grown to saturation, diluted in fresh galactose-containing media, and
incubated for 16h at 301C. Viability was determined from aliquots of cells stained with the vital dye trypan blue by visualization with light microscopy.
Data areexpressed as the percentage of cells that do not stain blue with the dye (% Trypan blue negative) and represent the mean of three independent
experiments ( SEM) , Student’s t-test Po0.01. (b) Wild-type cells transformed with either an empty vector (VECTOR) or a TSC22
(86)-expressing
plasmid were grown to logarithmic phase and treated with 5mM H2O2 (grey bars) or left untreated (black bars). Viability was determined using the vital
dye trypan blue as in Fig. 4a. Data represent the mean of three independent experiments ( SEM). , Student’s t-test Po0.01. (c) Wild-type cells
harboring the indicated combinations of empty vectors (VCRT) or YCA1- and TSC22
(86)-expressing plasmids wereincubated with 0.6mM H2O2 for 16h.
Viability was determined using with the vital dye trypan blue as in Fig. 4a. Data represent the mean of three different experiments ( SEM; Student’s
t-test: Po0.01 (d) Yeast cells harboring an empty vector (VECTOR) or the TSC22
(86) expressing plasmid were grown in galactose-containing media to
early logarithmic phase then incubatedwith or without 4mM H2O2 for 2h. The cultures werefurther incubatedfor 2h with 0.1mgmL
 1 of DHR 123 for
a further 2h. Samples of the different cultures were removed and examined by light (DIC) and ﬂuorescent light (DHR 123) microscopy. Representative
photographs are shown and the calculated proportion of 300 cells displaying a ﬂuorescent signal ( SEM) is indicated in boxes at the right.
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550 C.M. Khoury et al.encoding a full-length S. cerevisiae ORF fused to the Gal4p
activation domain (Uetz et al., 2000; Hazbun et al., 2003).
Eight positives resulting from this high-throughput screen
were retested for their ability to interact with Tsc22
(86),
resulting in the conﬁrmation of two interactions: Nkp1p,
which was originally identiﬁed as positive in both screens
and that yielded strong growth on two-hybrid selective
plates, and Erg6p, a positive that came up in a single screen
and showed weaker growth on the selective media. Both
interactions were speciﬁc, as shown by the inability of either
the Nkp1p or Erg6p protein to interact with Gal4p-DNA-
binding domain alone or a Gal4p-DNA-binding domain
fused toRad17p (Fig.5a). Surprisingly, noneof the184 yeast
LZ-containing proteins were identiﬁed as binding partners
of Tsc22
(86). This is in spite of the fact that the arraycontains
transformants for all of them, although it is not known
whether the Gal4p activation domain fusion proteins are
expressed.
Even though both Nkp1p and Erg6p lack any apparent LZ
motif in their primarysequence, we examined the possibility
that an interaction with either of these proteins was neces-
sary for the antiapoptotic function of Tsc22
(86). We tested
two possible hypotheses under which these interactions
might be required. The ﬁrst is that the Tsc22
(86) -interacting
proteins are proapoptotic and Tsc22
(86) serves to inhibit this
effect. A second scenario involves the formation of an
antiapoptotic complex consisting of Tsc22
(86) and Nkp1p
or Erg6p. We initially asked if Nkp1p has a role in yeast PCD
responses. WTyeast cells treated with H2O2 for 2.5h before
plating on nutrient containing agar media display a reduced
ability to form colonies when compared to untreated cells
(Fig. 5b). As compared to WT, an isogenic strain deleted for
NKP1 displayed a marked resistance to the effects of H2O2.
As a control we also examined yeast cells lacking the Nkp1p-
interacting protein encoded by the TRM7 gene. In contrast
to Dnkp1 cells, Dtrm7 cells displayed a hypersensitive
response to H2O2 (Fig. 5b). To conﬁrm the resistance
observed in cells lacking NKP1, we assessed their colony
forming ability when challenged with H2O2 after 2 and 3h,
respectively, 78.3% and 37.8% of cells remained clonogenic,
while only 32.9% and 3.6% of WT cells formed colonies
after these respective times of treatment (Fig. 5c). We next
tested if TSC22
(86) retained its anti-apoptotic effect in
yeast lacking NKP1. Transformants expressing TSC22
(86)
displayed a marked resistance to the effects of H2O2 on
clonogenicity of yeast (Fig. 5d and e). The proportion of
TSC22
(86)-expressing cells able to form colonies after 3h of
treatment was observed to be higher than that of vector-
transformed cells (TSC22
(86), 62.9( 2.9) %; VECTOR, 35.0
( 3.9) %; Fig. 5e). Thus despite the initial observation
suggesting that NKP1 is involved in apoptotic responses, we
ﬁnd that it is not required for the antiapoptotic effects of
TSC22
(86).
In order to test the effect of Erg6p overproduction on
PCD responses, we used a strain of yeast with the GAL1
promoter inserted upstream of the ERG6 gene (Tedrick
et al., 2004). It had been previously reported that induction
of the ERG6 gene (using 1% glucose and 1% galactose) was
sufﬁcient to promote increases in ergosterol levels (Tedrick
et al., 2004). Cells harbouring this insertion treated for 2.5h
with H2O2 displayed a marked reduction in growth as
compared with the parental strain (Fig. 5f). This reduction
in growth was signiﬁcantly more pronounced than the
modest reduction observed in untreated cells. These data
suggest that increased sterol levels render cells hypersensitive
to the effects of H2O2. We exploited this phenotype to ask
whether TSC22
(86) promotes cell survival through a me-
chanism involving Erg6p. ERG6-overexpressing cells that are
transformed with a TSC22
(86)-expressing vector were more
resistant to the effects of ERG6 overexpression on clono-
genicity, when compared to the same cells transformed with
an empty vector (Fig. 5g). This effect is likely nonspeciﬁc,
because the expression of Bax Sup. 32, an additional clone
identiﬁed the same functional lethality screen as TSC22
(86)
(C.M. Khoury & M.T. Greenwood, unpublished data),
conferred a comparable resistance to the effects of ERG6
overexpression (Fig. 5g). Finally, we examined the possibi-
lity that the prosurvival function of TSC22 is dependent on
ERG6. Cells lacking the ERG6 gene transformed with a
TSC22
(86)-expressing vector were signiﬁcantly more resis-
tant to the effects of H2O2 on clonogenicity with respect to
control cells [TSC22
(86), 44.0 ( 4.6) %; VECTOR, 12.4
( 3.7) %; Fig. 5h and i]. These data clearly indicate that
ERG6 is dispensable for the anti-apoptotic function of
TSC-22
(86).
TSC22
(86)-mediated antiapoptosis does not
require endogenous LZ-containing transcription
factors
We used a functional genomic approach to further test the
hypothesis that Tsc22
(86) functions by interacting with a
yeast LZ-containing TF (Kester et al., 1999; Uchida et al.,
2003). By searching the MIPS CYG database (Mewes et al.,
2006) for yeast genes encoding TFs with predicted leucine
zippers in their structure, we identiﬁed 19 such proteins: 17
of the bzip variety possessing a basic DNA binding domain,
and two LZ-containing TFs that also bear a helix–loop–
helix. Many of these genes have been shown to play
important roles in regulating gene expression in response
to different stressful stimuli. Forexample, Yap1p is known to
induce the expression of genes, such as heat shock proteins,
that are required for survival at elevated temperatures
(Rodrigues-Pousada et al., 2005). Therefore, this class of
proteins comprises potential candidates that interact with
and mediate the effects of Tsc22
(86). Among the 19 genes,
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et al., 2002). We initially tested the ability of strains
individually lacking the remaining 18 LZ-containing TF-
encoding genes to grow on minimal media containing
galactose, because these conditions required to induce the
expression of the TSC22
(86) cDNA from the GAL1 promoter.
When spotted on galactose-containing synthetic minimal
media, four of the strains (Drtg1, Drtg3, Dgcn4, and Dkcs1)
displayed moderate to severe growth defects (Fig. 6a).
Deletion of one of the genes (CST6) resulted in only a slight
impairment of growth, yet did not yield transformants with
the TSC22
(86)-expressing plasmid (not shown). There were
no observable growth defects for the other deletion strains
when spotted on galactose-containing media (Fig. 6a). We
therefore used these strains to ask if the expression of
TSC22
(86) retained its antiapoptotic effect in the absence
of these TFs (Fig. 6b). The strains were cotransformed with
different combinations of plasmids expressing BAX,
TSC22
(86), or Sup. 32. The expression of the proapoptotic
BAX protein effectively inhibited the growth of all strains
examined (Fig. 6b). Upon coexpression of TSC22
(86) with
BAX, the growth of each of the 13 strains was markedly
enhanced. The effect was not speciﬁc to TSC22
(86), however,
since Sup. 32 also served to reverse the effects of BAX in
these strains (Fig. 6b). This suggests that the antiapoptotic
effect of TSC22
(86) is independent of any individual LZ-
containing TF tested. Because this experiment required the
use of galactose-containing minimal media to induce gene
expression and maintain plasmid selection, we were unable
to test the function of TSC22
(86) for the ﬁve aforementioned
strains displaying growth defects. As an alternate approach
to determine if TSC22
(86) acts by forming a complex with
the remaining LZ motif-containing TFs that we were unable
to test, we assayed for an interaction between TSC22
(86) and
the TFs in the two-hybrid system. To this end, we fused the
TSC22
(86)-coding region in-frame with the LexA DNA-
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(86)), and constructed
Gal4p Activation domain fusions of each of three genes
(Gal4p-AD-Cst6p, Gal4p-AD-Rtg1p, and Gal4p-AD-
Rtg3p). We were unable to test Met4p, Gcn4p, or Kcs1p by
the two-hybrid assay here because of difﬁculties generating
stable plasmids with the PCR products of these genes.
Neither any of the AD fusions nor LexA-DBD-Tsc22
(86)
alone allowed for growth in the absence of exogenously
added histidine, indicating that the constructs do not auto-
activate the LexA-dependent HIS3 reporter (Fig. 6c). Yeast
cells co-expressing two previously known interacting pro-
teins (LexA-DBD-SMS1a and Gal4p-AD-WIPI49) served as
a positive control since they were able to grow in the absence
of exogenous histidine (Yang et al., 2007). Each of the AD-
fusions cotransformed with LexA-DBD-TSC22
(86) lead to
an undetectable level of growth in the absence of histidine,
suggesting that these LZ-containing TFs do not interact with
TSC22
(86) in the two-hybrid assay (Fig. 6c). The series of
experiments presented above indicates that ﬁnding a LZ-
mediated binding partner of TSC22
(86) is not a straight
forward proposition and suggests that the functions of
TSC22
(86) may not be mediated by LZ-containing TFs in
yeast (Figs 5 and 6).
The LZ motif of TSC22 is not necessary for its
antiapoptotic function
In order to directly test the requirement of the LZ motif of
TSC22
(86) in the observed antiapoptotic effect, we con-
structed and evaluated a series TSC22
(86) deletion mutants.
A schematic representation of the different TSC22
(86) mu-
tants is shown in Fig. 7a. We used yeast transformed with
these deletion mutants to assay for the retention of the
antiapoptotic function of TSC22
(86) (Fig. 7b). As observed
with TSC-22
(86), cells expressing either the TSC22
(D1 40) or
TSC22
(D57 86) mutants were notably more resistant to the
lethal effects of H2O2 as compared to control cells. In
contrast, we did not observe a protective effect in cells
transformed with either the TSC-22
(D1 56) or TSC-
22
(D41 86) deletions. We also tested the effect of these
deletion mutants on the accumulation of endogenous ROS
using the ROS-activated ﬂuorescent probe DHR123 (Fig.
7c). After treatment with H2O2, 65.9 ( 4.4) % and 69.6
( 3.1) % of cells that were transformed with either
TSC22
(D1 56) and TSC22
(D41 86), respectively, displayed a
ﬂuorescent signal. In cells expressing the TSC22
(D1 40) and
TSC22
(D57 86) mutants the observed proportion of such
Fig. 5. A genome-wide two-hybrid screen for TSC22
(86)-interacting proteins. (a) Tsc22
(86) interacts speciﬁcally with Nkp1p and Erg6p by a yeast two-
hybrid assay. Strains expressing Gal4 DNA-binding domain (Gal4DBD) or Gal4DBD fused to Rad17 or Tsc22
(86) were mated with yeast strains of the
opposite mating type expressing Gal4p activation domain (Gal4AD) or Gal4AD fused to Mec3p, Nkp1p or Erg6p. Diploids were selected and pinned on
media lacking tryptophan, leucine and histidine, and containing 1.5mM 3-aminotriazole. The Rad17-Mec3 pair serves as a positive control in this assay.
(b) Wild-type (WT), Dnkp1,a n dDtrm7 cells were incubated in minimal media to logarithmic phase before treatment with 4mM H2O2 for 2h. Samples
of each culture were removed, normalized for cell number, and spotted on nutrient-containing agar media and incubated for 2–3 days. (c) WT (black
bars) and Dnkp1 mutant (grey bars) cells were incubated in minimal media to logarithmic phase. Aliquots of each sample were removed prior to, as well
as after 2 and 3h of, treatment with 4mM H2O2. At each time point, an equal number of cells (250) from each sample were plated on nutrient-
containing agar media. The number of colonies formed was counted after 2 days of incubation at 301C. The data are expressed as the percentage (%)
cells that were plated that are capable of forming colonies (CFU). The data are representative of two different experiments. (d) Dnkp1 mutant cells
transformed with either an empty vector (VECTOR) or a TSC22
(86)-encoding vector were grown to logarithmic phase in galactose-containing minimal
media. Separate cultures of each sample were left untreated (CTL) or treated with 4mM H2O2 (1H2O2). After 3h of further incubation, aliquots were
removed and normalized for cell number, serially diluted, then spotted on nutrient-containing agar media and incubated for 2–3 days. Photographs of
the plates are shown. (e) Dnkp1 mutant cells transformed with either an empty vector (black bars) or a TSC22
(86)-encoding plasmid (grey bars) were
grownto logarithmic phase and treated with 4mM H2O2. Aliquots wereremovedat the times indicated, and 250 cells fromeach sample wereplated on
nutrient-containing agar media. The number of colonies formed was counted after 2 days of incubation at 301C. The data re expressed as the
percentage (%) cells that were plated that are capable of forming colonies (CFU). Data represent the mean of three independent experiments ( SEM).
(f) Galactose-inducible ERG6-overexpressing strain KTY3 (PGAL1-ERG6) and parental wild-type strain KTY1 (WT-ERG6) were grown to early logarithmic
phase in media containing glucose, galactose and rafﬁnose each to 1%. Cells were either left untreated (CTL) or treated with H2O2 to 1.2mM (1H2O2)
for 2h before spotting different serial dilutions of aliquots normalized for cell number on nutrient-containing agar media. Photographs of the plates
after 3 days of incubation at 301C are shown. (g) Cells of the galactose-inducible ERG6-overexpressing strain KTY3 (PGAL1-ERG6) transformed
individually with either empty vector (VECTOR) or with the vectors expressing the indicated proteins were grown to early logarithmic phase in media
containing glucose, galactose and rafﬁnose each to 1%. Cells were either left untreated (CTL) or treated with 1.2mM H2O2 (1H2O2) for 2h before
spotting different serial dilutions of aliquots normalized for cell number on nutrient-containing agar media. Photographs of the plates after 3 dayso f
incubation at 301C are shown. (H) Dnkp1 mutant cells transformed with either an empty vector (VECTOR) or a TSC22
(86)-encoding vector were grown
to early logarithmic phase in galactose-containing minimal media. Separate cultures of each sample were left untreated (CTL) or treated with H2O2 to
4mM(1H2O2). After 2h, aliquots were removed and normalized for cell number, serially diluted, then spotted on nutrient-containing agar media.
Photographs of the plates after 3 days of incubation at 301C are shown. (i) Derg6 cells transformed with either an empty vector (black bars) or a
TSC22
(86)-encoding plasmid (grey bars) were grown to early logarithmic phase in treated with 4mM H2O2. Aliquots were removed at the times
indicated, and an equal number of cells (250) from each sample were spotted on nutrient-containing media. The number of colonies formed was
counted after 2 days of incubation at 301C. The data are expressed as the percentage (%) cells that were plated that are capable of forming colonies
(CFU). Data represent the mean of three independent experiments ( SEM).
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553 Functional analysis of human Tsc22 in yeastROS-positive cells was respectively 12.0 ( 4.9) % and 11.8
( 4.1) %. Taken together these data demonstrate a prosur-
vival function for TSC22 that is independent of the LZ
motif, but instead requires a 16-residue sequence located at
the C-terminal portion of the conserved TSC22 domain.
TSC22-like motif present in yeast proteins Sno1p
and Fyv10p is sufficient to promote cell survival
in yeast
We examined the possibility that the 16-residue sequence
required for the antiapoptotic effects of Tsc22
(86) in yeast
represents a conserved motif present in other proteins.
Upon comparison of this putative motif to the available
protein sequences in GenBank, we identiﬁed a total of 19
proteins possessing similar 16-residue sequences. Among
thesequencesidentiﬁed were four yeastproteins that were of
potential interest since their antiapoptotic potential could
be easily tested using the yeast assays described in the
current study. Working under the hypothesis that Tsc22
(86)
acts by mimicking an endogenous yeast molecule, we
predicted that yeast proteins possessing similarity to the 16
residues necessary for the function of Tsc22
(86) might also be
antiapoptotic. An alignment of the amino acid sequences of
Sno1p (Fig. 8a) and Fyv10p (Fig. 8b) with that of Tsc22
(86)
reveals a cluster of conserved residues corresponding to the
16-residue region required for antiapoptosis. Sequences
outside this regions displayed relatively poor sequence
identity. We tested the ability of two of the yeast proteins
harboring the ‘Tsc22-like’ motif to promote cell survival in
yeast.Asshown in Fig.8c, cells harboring plasmids encoding
GFP alone displayed a reduction in viability upon treatment
with H2O2 for 2.5h. In contrast, cells expressing GFP fused
with either Sno1p or Fyv10p display a marked resistance to
the effects of H2O2. While only 6.0 ( 0.8)% of cells
harboring a vector expressing GFP alone retained the ability
to form colonies after treatment with H2O2 for 2.5h, the
proportion of Sno1p-GFP and Fyv10p-GFP expressing cells
remaining viable under these conditions was increased to
35.0 ( 1.5%) and 48.9 ( 1.6%), respectively (Fig. 8d).
These results indicate that overexpression of Sno1p and
Fyv10p served to signiﬁcantly delay death induced by an
Fig. 6. Analysis of the Bax suppressive properties
of Tsc22
(86) in yeast mutants lacking genes encod-
ing LZ motif-containing transcription factors.
(a) Strains of yeast deleted for the indicated genes
were grown overnight to saturation, serially
diluted, and spotted on galactose-containing nu-
trient agar minimal media and incubated for
3 days at 301C. (b) Yeast mutants lacking the
indicated genes were transformed with plasmids
expressing Bax alone (BAX) or in combination with
plasmids expressing TSC22
(86) (TSC22) or Bax
suppressor 32 (Bax Sup.32) were grown overnight
to saturation in glucose-containing media, serially
diluted and spotted onto both glucose- and galac-
tose-containing media (GLU and GAL, respec-
tively). A legend is shown at the top of the panel.
(c) Yeast strain DSY-1 expressing Gal4 DNA-bind-
ing domain (Gal4DBD) fused to TSC22
(86) or SMS1
was cotransformed with different vectors encod-
ing Gal4 activation domain (Gal4AD) fusions of
the indicated LZ-containing transcription factors or
WIPI49. Overnight cultures of each transformant
were serially diluted, and spotted on both histi-
dine-containing (1HIS) and histidine-deﬁcient
( HIS) nutrient-containing agar media. The
Gal4DBD-fused SMS1 and Gal4AD-fused WIPI49
pair serves as a positive control in this assay.
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apoptotic regulators, strains lacking the genes from which
they are produced are likely to be hypersensitive to the
effects of H2O2. Indeed, isogenic Dsno1 and Dfyv10 cells
displayed a pronounced sensitivity to the effects of H2O2
when compared to WT cells (Fig. 8e). After 2h treatment,
35.6 ( 2.8%) of WT cells retained the ability to form
colonies, as compared to 3.4% ( 0.7%) and 1.3 ( 0.5%)
for Dsno1 and Dfyv10 strains, respectively (Fig. 8f). These
data indicate that the ‘TSC22-like’ motif harboring proteins
Snop1p and Fyv10p are antiapoptotic.
Discussion
Direct phenotypic screens for antiapoptotic proteins in
which clones are identiﬁed on the basis that they prevent
cell death in response to a speciﬁc stimulus are technically
difﬁcult in most metazoan systems. In contrast, forward
genetic screens in simple genetic systems, such as C. elegans
and Drosophila melanogaster, have been extensively per-
formed in the past. Such screens have lead to the identiﬁca-
tion of many conserved apoptotic regulatory molecules,
including the central proapoptotic caspase-3, caspase-9,
and Apaf-1 (Hoeppner et al., 2004). More recently, several
groups have exploited the amenability of yeast to functional
screens to identify novel heterologous proteins capable of
suppressing the lethal effects of apoptotic stimuli (Kampra-
nis et al., 2000; Pan et al., 2001; Moon et al., 2002; Sawada
et al., 2003; Chen et al., 2004; Yang et al., 2006; Khoury et al.,
2007; Khoury & Greenwood, 2008). The human bax-inhi-
bitor I (BI-I) protein, for instance, was initially isolated in a
screen for suppressors of Bax in yeast, and has since been
shown to be an antiapoptotic factor conserved across plant,
animal, and fungal kingdoms (Xu & Reed, 1998). Sawada
et al. (2003) identiﬁed mammalian Ku70, a protein pre-
viously implicated in DNA damage repair, in a screen for
suppressors of the effects of Bax in yeast. Ku70 was found to
bind Bax and prevent its translocation to the mitochondria,
thereby serving as a speciﬁc inhibitor of Bax-mediated
apoptosis. Additional heterologous suppressors of apoptotic
stimuli identiﬁed inyeast-based screens included the tomato
glutathione peroxide, the soybean ascorbate peroxidase, and
both a Vesicle-Associated Membrane Protein (VAMP7) and
the Ethylene-Responsive-Element Binding Protein (AtEBP)
from Arabidopsis, the murine sphingomyelin synthase 1a
(Sms1a), and human Vacuolar protein sorting 24b
(VPS24b) (Kampranis et al., 2000; Pan et al., 2001; Moon
et al., 2002; Sawada et al., 2003; Chen et al., 2004; Yang et al.,
2006; Khoury et al., 2007). Therefore, screening heterolo-
gous cDNA libraries in yeast has proven to be an excellent
approach to identify novel antiapoptotic sequences.
In this study, we identify the 86 C-terminal residues of the
Tsc22 protein (denoted Tsc22
(86)) as a high-copy suppressor
of the deleterious effects of murine BAX expression in yeast
(Fig. 1). Tsc22
(86) represents the C-terminal TSC22-contain-
ing sequence encoded by the TSC22-1 gene and contains the
highly conserved 56aa LZ motif-containing domain known
Fig. 7. Analysis of the antiapoptotic properties of Tsc22
(86) deletion
mutants. (a) A schematic representation of Tsc22
(86), as well as the
deletion mutants that were generated by PCR. The PCR products were
cloned into the yeast expression vector p426GAL1. (b) Wild-type yeast
cells harboring empty plasmid (VECTOR) or different plasmids expressing
TSC22
(86) deletion mutants were grown to early logarithmic phase and
treated with 4mM H2O2 for 2.5h. Aliquots of untreated (CTL) and
treated (1H2O2) cells were diluted and spotted on nutrient-containing
agar media. (c) The levels of ROS were determined using the ﬂuorescent
dye DHR123 in yeast cells expressing the TSC22
(86) deletion mutants
indicated. Representative photographs of the light (DIC) and the corre-
sponding ﬂuorescent image (DHR123) for the four samples are shown.
The percentage of cells ( SEM) displaying a ﬂuorescent signal was
determined and is indicated in boxes at the right of rows corresponding
to each of the transformants.
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555 Functional analysis of human Tsc22 in yeastFig. 8. Analysis of the antiapoptotic properties of the yeast SNO1 and FYV10 genes an alignment of the amino acid sequence of Tsc22
(86) with the
sequences of Sno1p (a) and Fyv10p (b). CLUSTALW was used to align the sequences of Tsc22
(86) with Sno1p (GenBank accession #: NP_013813) and
Fyv10p (GenBank accession #: NP_012169). The regions corresponding to the 16-residue Tsc22
(86) sequence responsible for its anti-apoptotic function
are boxed. An asterisk () is used to indicate identical residues. Gaps denoted by dashes (‘-’) are introduced to maximize the possible similarity between
the aligned sequences. (c) Wild-type cells transformed with vectors expressing GFP alone (VECTOR) or GFP fused to the C-terminus of Sno1p or Fyv10p
were grown to early logarithmic phase in galactose-containing minimal media. Separate cultures of each sample were left untreated (CTL) or treated
with 4mM H2O2 (1H2O2) for 3h. Aliquots were removed and normalized for cell number, serially diluted, then spotted on nutrient-containing agar
media and incubated for 3 days. (d) Wild-type cells expressing GFP (VECTOR) with either an empty vector, or vectors encoding C-terminal GFP fusions
of Sno1p or Fyv10p were grown to logarithmic phase in treated with 4mM H2O2. Aliquots were removed at the times indicated, and an equal number
of cells from each sample were spotted on nutrient-containing media and incubated for 2 days. CFU were then scored and the data expressed as ‘% of
plated cells’. Data represent the mean of 3 independent experiments ( SEM). (e) Wild-type (WT), Dsno1, and Dfyv10 cells were grown to early
logarithmic phase in minimal media before cultures of each sample were left untreated (CTL) or treated with 2.5mM H2O2 for 2h (1H2O2). Aliquots
were removed and normalized for cell number, serially diluted, then spotted on nutrient-containing agar media and incubated for 2–3 days. Untreated
samples were also spotted on plates that were subsequently irradiated with UV light at 100mJcm
 2 (1UV), or incubated at elevated temperature
(381C), each with corresponding untreated control plates (CTL). (F) Wild-type (WT Dsno1,a n dDfyv10 cells were grown to early logarithmic phase in
minimal media before treatment with 2.5mM H2O2 for 2h. Aliquots were removed at the times indicated, and an equal number of cells from each
sample were spotted on nutrient-containing media and incubated for 2 days. CFU were then scored and the data expressed as ‘% of plated cells’. Data
represent the mean of three independent experiments ( SEM).
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556 C.M. Khoury et al.as TSC22 (Figs 1b and 2a) (Kester et al., 1999). Analysis of
this domain revealed that it is present in multiple proteins
of different sizes. We used the various TSC22-containing
proteins present in the GenBank database to determine that
there are four different alternately spliced human genes that
encode for a TSC22 motif (Figs 2 and 3). We conﬁrmed an
antiapoptotic role for the Tsc22
(86) by demonstrating that it
attenuated Bax- and H2O2-mediated cell death (Fig. 4a and
4b), as well as death induced by yeast caspase YCA1 over-
expression (Fig. 4c). We additionally showed that Tsc22
(86)
prevented H2O2-induced intracellular ROS accumulation,
a hallmark of apoptotic cells (Fig. 4d). Tsc22
(86) therefore
represents the most recent member in a growing list of both
endogenous and heterologous proteins that have been
shown to prevent apoptotic cell death in yeast (Walter
et al., 2006).
The TSC22 domain defines a multi-gene family
each encoding different proteins
The evolution of gene families is the result of different
processes such as duplication of regions of genes, whole
genes, or entire genomes and the recombination of protein-
coding sequences (Babushok et al., 2007). These phenomena
form the basis for the evolution of genetic diversity. The
divergences that can be observed between paralogous genes
(as a result of duplication events) or the generation of novel
roles for genes that have gained an additional functional
domain (as a result of exon shufﬂing) are extensively
documented outcomes of these events (Schmidt & Davies,
2007). For instance, a genome duplication event in a close
ancestor of S. cerevisiae is thought to have occurred, based in
part on the observation that more than 40%of its genesexist
as paralogous pairs (Wolfe, 2004). Alternatively, Liu et al.
compared protein domain architecture to exon-intron orga-
nization of genes across nine eukaryotic genomes (Liu &
Grigoriev, 2004). Their ﬁnding indicated a strong correla-
tion between the borders of protein domains and the ends of
exons and that this correlation increased with progressive
organismal complexity, providing evidence for the theory of
exon shufﬂing. We found that with regard to TSC22-1,
TSC22-3 and TSC22-4, their sequence identity is limited to
their common TSC22 domain-encoding regions (Figs 2 and
3). The presence of the TSC22 domain within the human
TSC22 gene family is likely to be the result of exon shufﬂing
events, with dissimilar pairs of genes being ‘converted’ by
gaining the TSC22 domain. The conserved TSC22 domain is
indeed speciﬁed by a single exon in all four human and
mouse genes and therefore appears to be in accordance with
the principles of the exon shufﬂing theory (Figs 2 and 3)
(Liu & Grigoriev, 2004; Fiol et al., 2007). On the other hand,
TSC22-1 and TSC22-2 share signiﬁcant sequence identity
outside the TSC22 domain, suggesting that these genes arose
by duplication. Diversity involving both duplication and
exon shufﬂing within the same gene family is commonly
observed (Jean-Baptiste et al., 2006).
More than half of human genes are thought to encode
alternately spliced products, suggesting the major impor-
tance of this mechanism in generating diversity within the
proteome (Johnson et al., 2003). It is widely recognized that
the proportion of different isoforms encoded by the same
gene is often altered in certain pathological states such as
cancer (Venables, 2006). Often a spliced transcript that is
selectively produced in pathological or stressful conditions
encodes for a protein with a different or regulatory function
with respect to the transcript expressed predominantly in
basal conditions (Venables, 2006). The signiﬁcance of this
regulatory mechanism is clearly evident with regard to genes
involved in apoptosis. For instance, the BCL-X pre-mRNA is
alternatively spliced to produce both pro- (Bcl-xS) and
antiapoptotic (Bcl-xL) isoforms. In addition to being mark-
edly upregulated in a number of tumors, the expression of
Bcl-xL is reduced (concomitant with an upregulation of Bcl-
xS) in cells treated with apoptotic stimuli (Boise et al.,
1993). As in this case, the selective up- or down-regulation
of a given isoform through alternative splicing is often an
important determinant of cell survival (Venables, 2006). We
found that in addition to our TSC22
(86) clone, the N-
terminally extended forms of the Tsc22-1 proteins are also
antiapoptotic when expressed in yeast (Fig. 2c). Separate
assays will be required in order to uncover the function of
the alternatively spliced variants of the TSC22 genes. In this
context, it is interesting to note that the TSC22-4 gene
encodes for a protein (Tsc-22-4v2) that lacks the antiapop-
totic TSC22 domain (Fig. 3c and f), suggesting a possible
dominant negative mode of action in cells coexpressing
different Tsc22-4 proteins. In addition, the observation that
a number of transcripts from different TSC22 genes are
upregulated in response to a variety of different stimuli
suggests that they may have a role to play in mediating stress
responses (Uchida et al., 2003; Fiol et al., 2007).
TSC22 is antiapoptotic independently of the LZ
motif in yeast
TSC22 domain-containing proteins are reported to have
effects on transcription by virtue of an embedded LZ motif.
Further, they are thought to be transcriptional modulators,
rather than direct TFs, due to the lack of any apparent DNA-
binding domain (Kawamata et al., 2004). It has been
proposed that Tsc22 functions through the heterodimeriza-
tion with cognate LZ motif-containing transcriptional reg-
ulators through an LZ mediated process (Kawamata et al.,
2004). This would likely involve either a gain-of-function or
a dominant inhibitory interaction between Tsc22 and the
putative LZ-containing protein. Similar paradigms have
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molecules (Vinson et al., 2002; Rangatia et al., 2003;
Thuerauf et al., 2004; Benito et al., 2006; Gonzalez et al.,
2007). For instance, the LZ-containing transcriptional acti-
vators c-jun and C/EBP-a have opposing effects on cell
proliferation. In a recent model of acute myeloid leukemia,
c-jun was shown to act by binding in an LZ-mediated
manner to the antiproliferative C/EBP-a protein. This
dominant negative inhibition of C/EBP-a prevented its
ability to bind DNA and thereby promote oncogenesis
(Rangatia et al., 2003). Another example of this mechanism
pertaining to the regulation of apoptosis involves thyro-
troph embryonic factor (TEF) and D-site-binding protein
(DBP), members of the proline- and acid-rich (PAR) basic
region LZ (bzip) proteins (Benito et al., 2006). TEF acts by
forming LZ-mediated homodimers that bind to the promo-
ter region to active the expression of the proapoptotic Bcl-gS
protein. An alternately spliced form of DBP (tDBP) that
lacks the transcriptional activation domain was shown to
prevent activation of the BCL-gS gene by competing with
TEF monomers and impairing the formation of a functional
heterodimer in a manner mediated by the LZ structure
(Benito et al., 2006). Based on the aforementioned descrip-
tions of the mechanisms by which Tsc22 has been proposed
to function, we used global yeast two-hybrid screening and
functional genomics, two separate and distinct approaches
to test this model for Tsc22
(86) in yeast.
In contrast to conventional cDNA library-based yeast
two-hybrid screens, the development of genome-wide
screening technologies have allowed comprehensive and
exhaustive screening for bait-interacting proteins. Uetz
et al. constructed an array of yeast transformants expressing
all of the recognized S. cerevisiae ORFs fused to a transcrip-
tional activation domain (Uetz et al., 2000). By mating these
strains with a strain expressing a bait-DNA-binding domain
fusion, an interaction between any desired protein and the
entire yeast proteome can be assayed in an automated,
binary fashion. For example, the yeast regulator of G-
protein signaling (RGS) Sst2p was used as bait in a
genome-wide two-hybrid screen that yielded 17 interacting
proteins. This resulted in the identiﬁcation of novel and
critical components of the Sst2p-regulated signaling path-
ways as evidence by the altered pheromone response of
strains lacking these genes (Burchett et al., 2002). Previous
groups have been successful in identifying LZ-mediated
interactions using the yeast two-hybrid system (Strathmann
et al., 2001; Weltmeier et al., 2006). Yeast two-hybrid screen-
ing for Tsc22-interacting proteins identiﬁed the LZ motif-
containing protein encoded by the TSC22-4 gene as a
binding partner of Tsc22 (Kester et al., 1999). While, in the
current study, a genome-wide two-hybrid analysis revealed
an interaction between Tsc22
(86) and two yeast proteins,
Nkp1p and Erg6p, we were surprised that neither of these
possessed a LZ structural motif as predicted by the analysis
of their primary sequences. Although these proteins may
indeed represent heterologous Tsc22
(86)-interacting part-
ners, we clearly demonstrated that their presence is not
required for the antiapoptotic function of Tsc22
(86) (Fig. 5e,
f, i and j)
Functional genomics approaches have been widely used
in studies using S. cerevisiae, due to the extensive resources
available and genetic amenability of this model system. In
a recent report, a set of strains harbouring deletions in
previously uncharacterized small ORFs (sORFs) was con-
structed. This study provided an array of phenotypic
descriptions for a number of strains lacking these sORFs,
including information on growth rates, heat-shock re-
sponse, responses to DNA damaging agents, and growth
under respiratory conditions (Kastenmayer et al., 2006).
Manyof thesesORFs werealso shown to be conserved across
eukaryotes (Kastenmayer et al., 2006). Therefore, the func-
tional genomic analysis served to reveal biological functions
for an important class of genomic elements. While studying
the phospho-regulation of the amphiphysin yeast ortholog
Rvs167p, the Andrews group screened a panel of yeast
deletion strains to discover that a nonphosphorylatable
mutant form of this protein prompted lethality in a subset
of strains displaying defects in the actin cytoskeleton (Frie-
sen et al., 2003). This observation indicated that Rvs167p
phosphorylation is a key event in the regulation of actin
cytoskeleton-associated complexes (Friesen et al., 2003).
Finally, the dependency that Bax-mediated cell death dis-
plays on the respiratory status of yeast was demonstrated by
examining the function of Bax in a set of mutant yeast
strains with speciﬁc respiratory-defects (Harris et al., 2000).
By further demonstrating that expression of the heterolo-
gous Bax protein causes respiratory dysfunction in yeast,
this study bulwarked the notion that Bcl-2 family members
can act independently (the yeast genome is devoid of any
apparent BCL-2 orthologs) to alter mitochondrial physiol-
ogy (Harris et al., 2000). Our functional genomic analysis of
Tsc22
(86) in strains lacking genes that encode LZ-containing
TFs comprises the ﬁrst description of the collective panel of
strains deleted for LZ-containing TFs (Fig. 6). A number of
these proteins have been extensively implicated in the
regulation of stress responses in yeast and therefore likely to
be involved in the apoptotic programme. For instance, the
expression of a number of genes encoding the LZ-contain-
ing TFs, such as YAP4 and YAP6, are induced bya number of
apoptotic stimuli, including heat, osmotic and oxidative
stresses (Rodrigues-Pousada et al., 2005). In addition, the
stress-induced expression of genes encoding a number of
antioxidant proteins, including TRX2, is dependent on the
bzip TF Yap1p (Alarco& Raymond, 1999). Kililiet al. (2004)
identiﬁed a class of tomato Glutathione S-transferases that
suppress oxidative stress-induced cell death in yeast. This
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gene, providing further evidence for the role of Yap1 in
oxidative stress responses. Our results suggest that the
antiapoptotic function of Tsc22
(86) is not dependent on any
individual LZ-containing yeast TFs (Fig. 6). This is consis-
tent with the lack of LZ-containing proteins in our ﬁndings
from the global two-hybrid screen (Fig. 5).
Structure/function studies using deletion mutants of
Tsc22-1v3 have attributed roles to both the conserved and
nonconserved regions of the protein. For instance, mutants
of Tsc22-1v3deleted for twoindependent regions atﬂanking
ends of the conserved TSC22 domain displayed a reduced
ability to act as a repressor in a reported-based transcrip-
tional activity assay in COS-I cells. This allowed for the
identiﬁcation of two repressor domains (RD1 and RD2) in
the nonconserved portions of the Tsc22-1v3 protein (Kester
et al., 1999). Hino et al. (2002) demonstrated that over-
expression of the LZ domain from the same Tsc22 protein
resulted in a more pronounced inhibition of anchorage-
independent colony formation in a salivary gland cancer cell
and CHO cell lines when compared to the full length
protein. These results suggest that the LZ structure of
Tsc22-1v3 is a functional domain that serves to suppress
tumour cell growth. More recently, the expression of a
mutant lacking the N-terminal 26 residues of the TSC22
domain (yet retaining the LZ motif) failed to promote the
growth-inhibitory effect observed upon expression of full-
length Tsc22 in Xenopus laevis cells (Hashiguchi et al., 2007).
Therefore, there is evidence for both LZ motif-dependent
and independent functions for Tsc22-1v3 in the literature.
Our ﬁnding that deletion mutants lacking the LZ motif
retain the antiapoptotic function clearly demonstrates a LZ-
independent function for Tsc22
(86) in yeast. In effect, our
results suggest that a 16aa stretch C-terminal to the LZ
motif is necessary for the prosurvival effect. Our ﬁndings
demonstrate the requirement of a previously unrecognized
region in the pro-survival function of Tsc22
(86).
The ‘Tsc-22-like’ motif predicts an antiapoptotic
role for SNO1 and FYV10
Deletion analyses have been tremendously successful at
identifying functional domains for a large number of
different genes (Reed et al., 1996). Examples include genes
encoding the Bcl-2 homology domains (BH1–BH4), present
in the Bcl-2 family of pro- and antiapoptotic proteins (Reed
et al., 1996). BH domains are comprised of short sequences
that form common tertiary structures such as a helices.
Their importance is demonstrated by the ﬁnding that
deletion of any of the BH domains of Bcl-2, including the
BH1 (28aa), BH2 (15aa), or BH3 (13aa) abrogates its
ability to mediate antiapoptosis (Reed et al., 1996). Impor-
tantly, the presence of BH domains in other proteins has
allowed the identiﬁcation of other Bcl-2 family members
with roles in the regulation of apoptosis (Adams & Cory,
1998). In the current study, we have identiﬁed a 16-residue
sequence, comparable in length to the BH domains, within
the conserved TSC22 domain that is required for the
antiapoptotic effect of Tsc22
(86) in yeast. In a manner
analogous to the aforementioned BH domain studies, we
used BLAST to identify 19 different proteins that contain a
sequence similar to the antiapoptotic TSC22 motif. Thus,
we predicted that these ‘TSC22-like’ proteins might repre-
sent a novel class of antiapoptotic sequences. We tested this
prediction by analyzing two of the four yeast genes identi-
fied, namely SNO1 and FYV10 (Fig. 8). Both genes were
found to be antiapoptotic since their overexpression pro-
tected cells from H2O2 (Fig. 8c and d). Additionally, strains
lacking these genes were considerably more sensitive to the
effects of H2O2 (Fig. 8e and d). Thus, our characterization of
Tsc22
(86) in yeast has served to functionally identify novel
antiapoptotic genes. Based on our data, other proteins
possessing the Tsc22-like motif are strong candidates for
proteins with antiapoptotic function.
SNO1 was originally identiﬁed on the basis of its proxi-
mity to SNZ1, a related gene with which it is coordinately
regulated in a growth-phase dependent manner. For in-
stance, both genes are upregulated during the diauxic shift
that occurs upon entrance into stationary phase, and have
been proposed to be involved in the adaptive response to
nutrient limitation (Padilla et al., 1998). In addition, Sno1p
has been reported to function as a glutaminase in a manner
dependent on Snz1p, serving to promote pyridoxine bio-
synthesis (Rodriguez-Navarro et al., 2002; Dong et al.,
2004). Theabilityof Sno1pto protect fromoxidative stresses
may be simply due to an elevation in the levels of vitamin
B6, a molecule with known ROS scavenging functions
(Osmani et al., 1999). The deletion of SNO1 had been
previously reported to resultin hypersensitivity to inhibitors
of purine and pyrimidine biosynthesis, as well as ROS-
generating agents (Padilla et al., 1998). In yeast, SNO1 is
part of a multigene family that includes SNO2 and SNO3
(Padilla et al., 1998). Although the 222 residue Sno2p and
Sno3p differ in only two residues, they are only 65%
identical to the 224 residue Sno1p. Of the 16 TSC22 motif
present in Sno1p, only 11 are conserved in Sno2p and
Sno3p. In addition, to differences in sequences and differ-
ences in their regulation, Sno2 and Sno3 double knockouts,
unlike Dsno1 strains, have normal sensitivity to inhibitors of
purine and pyrimidine biosynthesis. Thus they appear to be
less likely to be involved in stress response.
FYV10 was identiﬁed in a screen for mutants hypersensi-
tive to the death inducing effects of viral killer toxin K1
(Page et al., 2003). Although this study is suggestive of a role
for FYV10 in the regulation of apoptosis, it should be noted
that a great number of genes have been identiﬁed as
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they are knocked-out (Page et al., 2003; Scherens & Goffeau,
2004). Despite these phenotypes, only a subset of these genes
is expected to confer resistance to these stresses when over-
expressed, and therefore be bona ﬁde anti-apoptotic regula-
tors (Khoury et al., 2007). Our study is the ﬁrst to clearly
demonstrate the importance of FYV10 in preventing death
in response to apoptotic stimuli.
It is worth noting that Fyv10p possesses a conserved
CTLH domain, within which is the 16-residue ‘Tsc22-like’
sequence. There are four yeast proteins with CTLH domains
(Regelmann et al., 2003). All four are encoded by the so-
called GID genes, deﬁned by a function in the proteosome-
dependent glucose-induced catabolite degradation of the
gluconeogenic enzyme fructose-1,5-bisphosphatase (Regel-
mann et al., 2003). The potential role of these proteins in
regulating apoptosis is at present unknown. Interestingly,
the human erythroblast macrophage protein (Emp) shares
22–30% identity to Fyv10p throughout much of its se-
quence. While Emp has been suggested to perform an
antiapoptotic function, the mechanistic details are currently
unknown (Hanspal et al., 1998).
Conclusion
The use of yeast as a heterologous system to dissect the
structure and function of mammalian genes has a long
history (Hartwell, 2002). Functional analysis in yeast of
mutant Bax lacking critical residues within the BH3
domain pointed to the importance of this domain in Bax-
mediated apoptosis in mammalian cells (Zha et al., 1996).
Although yeast has been used to study metazoan proteins
involved in apoptosis, our study is one of the ﬁrst to
demonstrate that the similarity between mammalian and
yeast apoptosis allows the detailed analysis of a heterologous
apoptotic regulator. The current study also provides a clear
illustration of the insight that can be gained through such an
analysis.
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